Physician profile
Dalal Eldick
NPI 1598185993
$1,908.59
in general payments reported to CMS, 2019-2025
18 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $71.16 · 2021: $201 · 2022: $416 · 2023: $173 · 2024: $290 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $504.24 | 2019-2023 | |
| Astellas Pharma US INC | $406.21 | 2019-2025 | Veozah |
| Novo Nordisk INC | $317.11 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Allergan, INC. | $121.21 | 2019 | |
| Medtronic, INC. | $113.58 | 2022-2024 | Plasmablade(Tm) |
| Mayne Pharma Commercial LLC | $89.49 | 2021-2022 | |
| Roche Diagnostics Corporation | $75.11 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.63 | 2020-2025 | Vpriv |
| Pfizer INC. | $36.50 | 2022-2023 | |
| Organon LLC | $36.25 | 2022-2023 | Nexplanon |
| Minerva Surgical, INC | $34.62 | 2022-2025 | |
| Biogen, INC. | $26.35 | 2024 | Zurzuvae |
| Duchesnay USA Incorporated | $24.99 | 2019 | |
| Daiichi Sankyo INC. | $24.79 | 2022 | |
| Hologic Sales and Service, LLC | $15.79 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalpropion Pharmaceuticals LLC | $13.58 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.75 | 2019 | |
| Channel Medsystems, INC. | $5.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dalal Eldick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.